Cargando…
Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 when used as nutritional additive or as feed flavouring...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009086/ https://www.ncbi.nlm.nih.gov/pubmed/32626314 http://dx.doi.org/10.2903/j.efsa.2019.5689 |
_version_ | 1783495588303601664 |
---|---|
author | Bampidis, Vasileios Azimonti, Giovanna Bastos, Maria de Lourdes Christensen, Henrik Dusemund, Birgit Kouba, Maryline Kos Durjava, Mojca López‐Alonso, Marta López Puente, Secundino Marcon, Francesca Mayo, Baltasar Pechová, Alena Petkova, Mariana Sanz, Yolanda Villa, Roberto Edoardo Woutersen, Ruud Costa, Lucio Cubadda, Francesco Dierick, Noël Flachowsky, Gerhard Glandorf, Boet Herman, Lieve Mantovani, Alberto Saarela, Maria Wallace, Robert John Anguita, Montserrat Tarrés‐Call, Jordi Ramos, Fernando |
author_facet | Bampidis, Vasileios Azimonti, Giovanna Bastos, Maria de Lourdes Christensen, Henrik Dusemund, Birgit Kouba, Maryline Kos Durjava, Mojca López‐Alonso, Marta López Puente, Secundino Marcon, Francesca Mayo, Baltasar Pechová, Alena Petkova, Mariana Sanz, Yolanda Villa, Roberto Edoardo Woutersen, Ruud Costa, Lucio Cubadda, Francesco Dierick, Noël Flachowsky, Gerhard Glandorf, Boet Herman, Lieve Mantovani, Alberto Saarela, Maria Wallace, Robert John Anguita, Montserrat Tarrés‐Call, Jordi Ramos, Fernando |
collection | PubMed |
description | Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 when used as nutritional additive or as feed flavouring compound in feed and water for drinking for all animal species. The product under assessment is l‐leucine produced by fermentation with a genetically modified strain of E. coli (NITE BP‐02351). The production strain and its recombinant DNA were not detected in the final products. l‐Leucine, manufactured by fermentation with E. coli NITE BP‐02351, does not give rise to any safety concern to the production strain. The use of l‐leucine produced with E. coli NITE BP‐02351 is safe for the target species when used to supplement the diet in appropriate amounts. It is safe at the proposed use level of 25 mg/kg when used as flavouring compound for all animal species. The use of l‐leucine produced by fermentation with E. coli NITE BP‐02351 in animal nutrition raises no safety concerns for consumers of animal products. The additive is not irritating to the skin or eyes and is not a skin sensitiser. There is a risk for persons handling the additive from the exposure to endotoxins by inhalation. The use of l‐leucine produced by E. coli NITE BP‐02351 as feed additive does not represent a risk to the environment. The additive l‐leucine produced by E. coli NITE BP‐02351 is regarded as an effective source of the amino acid l‐leucine when used as nutritional additive. For the supplemental l‐leucine to be as efficacious in ruminants as in non‐ruminant species, it requires protection against degradation in the rumen. It is also considered efficacious as feed flavouring compound under the proposed conditions of use. |
format | Online Article Text |
id | pubmed-7009086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70090862020-07-02 Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species Bampidis, Vasileios Azimonti, Giovanna Bastos, Maria de Lourdes Christensen, Henrik Dusemund, Birgit Kouba, Maryline Kos Durjava, Mojca López‐Alonso, Marta López Puente, Secundino Marcon, Francesca Mayo, Baltasar Pechová, Alena Petkova, Mariana Sanz, Yolanda Villa, Roberto Edoardo Woutersen, Ruud Costa, Lucio Cubadda, Francesco Dierick, Noël Flachowsky, Gerhard Glandorf, Boet Herman, Lieve Mantovani, Alberto Saarela, Maria Wallace, Robert John Anguita, Montserrat Tarrés‐Call, Jordi Ramos, Fernando EFSA J Scientific Opinion Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 when used as nutritional additive or as feed flavouring compound in feed and water for drinking for all animal species. The product under assessment is l‐leucine produced by fermentation with a genetically modified strain of E. coli (NITE BP‐02351). The production strain and its recombinant DNA were not detected in the final products. l‐Leucine, manufactured by fermentation with E. coli NITE BP‐02351, does not give rise to any safety concern to the production strain. The use of l‐leucine produced with E. coli NITE BP‐02351 is safe for the target species when used to supplement the diet in appropriate amounts. It is safe at the proposed use level of 25 mg/kg when used as flavouring compound for all animal species. The use of l‐leucine produced by fermentation with E. coli NITE BP‐02351 in animal nutrition raises no safety concerns for consumers of animal products. The additive is not irritating to the skin or eyes and is not a skin sensitiser. There is a risk for persons handling the additive from the exposure to endotoxins by inhalation. The use of l‐leucine produced by E. coli NITE BP‐02351 as feed additive does not represent a risk to the environment. The additive l‐leucine produced by E. coli NITE BP‐02351 is regarded as an effective source of the amino acid l‐leucine when used as nutritional additive. For the supplemental l‐leucine to be as efficacious in ruminants as in non‐ruminant species, it requires protection against degradation in the rumen. It is also considered efficacious as feed flavouring compound under the proposed conditions of use. John Wiley and Sons Inc. 2019-05-03 /pmc/articles/PMC7009086/ /pubmed/32626314 http://dx.doi.org/10.2903/j.efsa.2019.5689 Text en © 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Scientific Opinion Bampidis, Vasileios Azimonti, Giovanna Bastos, Maria de Lourdes Christensen, Henrik Dusemund, Birgit Kouba, Maryline Kos Durjava, Mojca López‐Alonso, Marta López Puente, Secundino Marcon, Francesca Mayo, Baltasar Pechová, Alena Petkova, Mariana Sanz, Yolanda Villa, Roberto Edoardo Woutersen, Ruud Costa, Lucio Cubadda, Francesco Dierick, Noël Flachowsky, Gerhard Glandorf, Boet Herman, Lieve Mantovani, Alberto Saarela, Maria Wallace, Robert John Anguita, Montserrat Tarrés‐Call, Jordi Ramos, Fernando Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species |
title | Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species |
title_full | Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species |
title_fullStr | Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species |
title_full_unstemmed | Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species |
title_short | Safety and efficacy of l‐leucine produced by fermentation with Escherichia coli NITE BP‐02351 for all animal species |
title_sort | safety and efficacy of l‐leucine produced by fermentation with escherichia coli nite bp‐02351 for all animal species |
topic | Scientific Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009086/ https://www.ncbi.nlm.nih.gov/pubmed/32626314 http://dx.doi.org/10.2903/j.efsa.2019.5689 |
work_keys_str_mv | AT safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT bampidisvasileios safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT azimontigiovanna safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT bastosmariadelourdes safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT christensenhenrik safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT dusemundbirgit safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT koubamaryline safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT kosdurjavamojca safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT lopezalonsomarta safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT lopezpuentesecundino safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT marconfrancesca safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT mayobaltasar safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT pechovaalena safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT petkovamariana safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT sanzyolanda safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT villarobertoedoardo safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT woutersenruud safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT costalucio safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT cubaddafrancesco safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT diericknoel safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT flachowskygerhard safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT glandorfboet safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT hermanlieve safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT mantovanialberto safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT saarelamaria safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT wallacerobertjohn safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT anguitamontserrat safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT tarrescalljordi safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies AT ramosfernando safetyandefficacyoflleucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies |